Remedium Lifecare Ltd.
Remedium Lifecare Ltd. (REMLIFE.BO) Stock Overview
Explore Remedium Lifecare Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
749.7M
P/E Ratio
6.11
EPS (TTM)
$0.13
ROE
0.20%
REMLIFE.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Remedium Lifecare Ltd. (REMLIFE.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 53.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 6.11 and a market capitalization of 749.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.